SCHEMBL95287

SCHEMBL95287

CCCCCCc1ccccc1-c1noc(C[O])n1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARA Q07869 1/20 0.47
NR1H2 P55055 1/20 0.45
NR1H3 Q13133 1/20 0.45
KDM4E B2RXH2 1/20 0.44
HDAC1 Q13547 2/20 0.44
HDAC2 Q92769 2/20 0.44
HDAC8 Q9BY41 2/20 0.44
TSHR P16473 2/20 0.43
MEN1 O00255 1/20 0.43
LMNA P02545 1/20 0.43
HTT P42858 1/20 0.43
KMT2A Q03164 1/20 0.43
SPHK1 Q9NYA1 1/20 0.43
ATM Q13315 1/20 0.42
LIPG Q9Y5X9 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
ALDH1A1 P00352 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
PTPN1 P18031 1/20 0.40
MAPT P10636 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL97644 0.91 PPARA (0.50) PPARANR1H2NR1H3KDM4EHDAC1
SCHEMBL95288 0.88 NOTUM (0.50) PPARANR1H2NR1H3KDM4EHDAC1
SCHEMBL97645 0.85 PPARA (0.50) PPARAKDM4EHDAC1HDAC2HDAC8
SCHEMBL3939828 0.82 ATM (0.41) KDM4EHDAC1HDAC2HDAC8TSHR
SCHEMBL96220 0.77 MAPT (0.46) NR1H2NR1H3KDM4EMEN1LMNA
SCHEMBL9619382 0.75 LIPG (0.62) PPARANR1H2NR1H3LIPGPTPN1
SCHEMBL11663988 0.75 LIPG (0.62) PPARANR1H2NR1H3LIPGPTPN1
SCHEMBL196217 0.75 LIPG (0.62) PPARANR1H2NR1H3LIPGPTPN1
SCHEMBL8157124 0.75 LIPG (0.62) PPARANR1H2NR1H3LIPGPTPN1
SCHEMBL1921650 0.75 LIPG (0.62) PPARANR1H2NR1H3LIPGPTPN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8362252-B2 Carbostyril compound OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2013-01-29 US disclosed
EP-1797082-B1 CARBOSTYRIL COMPOUND OTSUKA PHARMA CO LTD (JP) 2012-08-29 EP disclosed
EP-2426128-A1 Carbostyril compound Otsuka Pharmaceutical Co., Limited (JP) 2012-03-07 EP disclosed
US-20100261705-A1 CARBOSTYRIL COMPOUND OTSUKA PHARMACEUTICAL CO., LTD. 2010-10-14 US disclosed
US-7777038-B2 Carbostyril compound OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2010-08-17 US disclosed
US-20090326008-A1 NF-kappa B Inhibitor OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2009-12-31 US disclosed
US-20070179173-A1 Carbostyril compound OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2007-08-02 US disclosed
EP-1797082-A1 CARBOSTYRIL COMPOUND Otsuka Pharmaceutical Company, Limited (JP) 2007-06-20 EP disclosed
WO-2006035954-A1 CARBOSTYRIL COMPOUND OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2006-04-06 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090326008-A1 NF-kappa B Inhibitor NFKBIA, NFKB2, IKBKB PPARA 3385/4885NR1H2 168/4885NR1H3 223/4885
US-20070179173-A1 Carbostyril compound GTF2F1, F3, GTF2F2 PPARA 1465/4885NR1H2 287/4885NR1H3 339/4885
US-20100261705-A1 CARBOSTYRIL COMPOUND GTF2F1, F3, GTF2F2 PPARA 1465/4885NR1H2 287/4885NR1H3 339/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.